Watch Ticker

Delcath Systems Inc

Go to Delcath Systems Inc Website

$0.00

(%)

Live

Previous Close

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$160.3 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - How Much Upside is Left in Delcath Systems (DCTH)? Wall Street Analysts Think 244.83%

The mean of analysts' price targets for Delcath Systems (DCTH) points to a 244.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Related tickers: DCTH.

Read Full Article

Zacks Equity Research - Can Delcath Systems (DCTH) Climb 277.73% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 277.7% upside potential for Delcath Systems (DCTH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Related tickers: DCTH.

Read Full Article

Trending Tickers

CRIS

XNAS

$0.00

(%)

CVNA

XNYS

$0.00

(%)

LASE

XNAS

$0.00

(%)

XNYS

$0.00

(%)

MLGO

XNAS

$0.00

(%)